Abstract Introduction Urinary tract infections (UTIs) are among the most frequent infections in
clinical practice worldwide. Their frequency and burden must be higher than available data …

Antimicrobial resistance in bacterial pathogens is a worldwide challenge leading high
morbidity and mortality in clinical settings. Multidrug resistant patterns in gram-positive and …

Fosfomycin was discovered over four decades ago, yet has drawn renewed interest as an
agent active against a range of multidrug-resistant (MDR) and extensively drug-resistant …

Introducción Las infecciones del tracto urinario (ITU) son frecuentes en la comunidad. Sin
embargo, la información de aislamientos resistentes en este contexto es limitada en …

There has been growing interest in fosfomycin for the treatment of bacterial prostatitis due to
evidence suggesting that it achieves adequate prostatic concentrations for antimicrobial …

Hybrid strains of Escherichia coli combine virulence traits of diarrheagenic (DEC) and
extraintestinal pathogenic E. coli (ExPEC), but it is poorly understood whether these …

Occurrence of urosepsis is not uncommon following urinary tract infections (UTI). However,
there is a lack of evidence explaining the risk factors predisposing to urosepsis in patients …

Objective Urinary tract infections (UTIs) are among the most frequently seen community-
acquired infections worldwide. E. coli causes 90% of urinary system infections. To guide the …

Background The aim of this study was to compare short-and long-term mortality among
patients with urosepsis caused by Escherichia coli susceptibile (EC-SC) and resistant (EC …

Urinary tract infections (UTIs) are often caused by Escherichia coli. Their increasing
resistance to broad-spectrum antibiotics challenges the treatment of UTIs. Whereas, E. coli …